One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2021-146306
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 17 |
Affiliation: Goethe University Frankfurt, University Hospital Frankfurt, Paracelsus Medizinische Privatuniversität, Charité - Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, Freie Universität Berlin, University of Münster, Rechts der Isar Hospital, University Medical Center Freiburg, University of Freiburg, Universitätsklinikum Tübingen, University Hospital Ulm, University Hospital Cologne, Robert Bosch Hospital, Universität Hamburg, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, German Cancer Research Center, Heidelberg University, Essen University Hospital, University of Lübeck, University Hospital Schleswig-Holstein, Ludwig-Maximilians-Universität München, LMU Klinikum, Heinrich Heine University Düsseldorf, Klinik und Poliklinik für Psychosomatische Medizin und Psychotherapie, University Hospital Würzburg, Leipzig University
First Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 705 Adults with Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL/LBL)
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
